Accessibility Tools

Uma Bhandari

Download CV

Uma Bhandari

Email : ubhandari@jamiahamdard.ac.in

View Google Scholar

PERSONAL INFORMATION

Alternate Email :

uma_bora@hotmail.com

Designation :

Professor

Department & School :

Department of Pharmacology & School of Pharmaceutical Education and Research (SPER)

Qualifications :

Phd in Pharmacy University of Delhi, M.Pharm University of Delhi, B.Pharma Univeristy of Delhi

State Of Domicile :

Delhi

Research Thrust Areas :

Cardio Metabolic Disorders including atherosclerosis, obesity, diabetes

Details Of Courses Taught

M.Pharm (Pharmacology), B.Pharma, D.Pharma , General Pharmacology, Chemotherapy and Practicals in Pharmacology in Medical colleges

PUBLICATIONS

BOOKS & BOOK CHAPTERS PUBLISHED

Number Of Books Published By National Publisher :

  1. A Textbook of Pharmacology.2011, Biotech Pharma Publications, Chennai, India     (ISBN: 978-93- 80682- 02-0).
  2. Introduction to Experimental Pharmacology. 2010, 1st edition, Birla Publications, Delhi, India (ISBN: 818974789-4).
  3. A Text book of Pharmacology for B. Pharma, 1998, Piyush Publications, Delhi, India (ISBN: 81-86548-02-7)
  4. Pharmacology & Toxicology by Uma Bhandari & Shamim Ahmed, 1995, Piyush Publications, Delhi, India (ISBN:81-86548-21-1)

The Name Of The Publisher :

1. Biotech Pharma Publications, Chennai, India   

2. Birla Publications, Delhi, India 

3.  Piyush Publications, Delhi, India

4.  Piyush Publications, Delhi, India

Number Of Books Published By International Publisher :

Nill

The Name Of The International Publisher :

Nill

Number Of Book Chapters In Edited Books Of National Publishers :

Nill

The Name Of The Publisher:

Nill

Number Of Book Chapters In Edited Books Of International Publishers :

Nill

The Name Of The Publisher :

Nill

RESEARCH GRANTS AND CONSULTANCY PROJECTS

Number Of Research Grants From Govt. Funding Agencies As PI/Coordinator :

S. No.

Investigator

Title of the Project

Funding Body

Funds Sanctioned / Applied for

1.

Principal Investigator

(3 years Major Research Project: 2015-2018) (UGC)

Project is sanctioned on 26.12.2014

Study of gut microbiota-induced atherosclerosis and obesity and modulation by Embelin in rats

University Grants Commission (UGC)

Candidate ID: MRP-MAJOR-PHAR-2013-39022

Interview held on 24.12.2014

Results were declared on 26.12.2014

Rs. 13,52,000/-

2.

Principal Investigator

(3 years Major Research Project: 2004-2007)

Pharmacological Investigations of Embelia ribes for cardioprotective and antioxidant activities in models of oxidative stress in diabetic rats

(Major Research Project)

UGC

F. no.: F-12/2004/SR;

Dated. 29-12-2003, from 1-4-2004 to 31-3-2007. 

 

Rs. 8,37,000/-

3.

Principal Investigator

(2 years Major Research Project : 2007-2009)

To Evaluate the Effect of Embelia ribes Extracts on Myocardial Infarction & Cerebral Ischemia in Models of Oxidative Stress in Rats

F. no.: 8023/BOR/RPS-

156/2006-07, dated:  February 26, 2007 All India Council of Technical Education (AICTE)

 

 

Period: April, 2007 –

March, 2009

 

Rs. 6.9 Lakhs

4.

Principal Investigator

(3 years Major Research Project: 2008-2011)

Evaluation of Gymnema sylvestre extract (gurmar) for antiobesity activity in normal and diabetic albino rats

UGC

F. No. 33-117/2007(SR), Dated: 28th February, 2008

 

Period: April, 2008 – March, 2011

 

Rs. 10,76,800/-

5.

Principal Investigator

(3 years Major Research Project: 2009-2012)

Pharmacological investigation on Embelia ribes (Vidanga) for antiobesity activity in rats

Central Council of Research in Ayurveda & Siddha (CCRAS), Department of Ayush, Ministry of Health

F. No. 5-29/2006/CCRAS/ Teck/Hq/EMR,

Dated: 04/10/2007

F.No.Z.31014/02/2009/EMR-CCRAS dated 21/08/2009

 

 

Rs. 15,32,000/-

Name Of The Agency And Amount Of Funding Generated :

1. University Grants Commission (UGC) Ammount: Rs. 13,52,000/- 

2. University Grants Commission (UGC) Ammount: Rs. 8,37,000/-

3. All India Council of Technical Education (AICTE) Ammount: Rs. 6.9 Lakhs

4. University Grants Commission (UGC) Ammount: Rs. 10,76,800/-

5. Central Council of Research in Ayurveda & Siddha (CCRAS), Department of Ayush, Ministry of Health Ammount: Rs. 15,32,000/-

6.  University Grants Commission (UGC) Ammount:Rs. 16,000/-

Number Of Research Grants From Govt. Funding Agencies As Co-PI :

Nill

Name Of The Agency And Amount Of Funding Generated :

Nill

Number Of Research Grants From International And Private Sources As PI :

Nill

Name Of The Agency And Amount Of Funding Generated :

Number Of Consultancy Projects :

Nill

Name Of The Agency And Amount Of Funding Generated :

Nill

RESEARCH SUPERVISION

Number Of Master’s Theses/DissertationsGuided :

46


Number Of Ph.D. Guided :

16

Number Of Master’s Theses/DissertationsGuided :

Nill

Number Of Co-supervisorPhd :

3

PATENTS

Number Of Patents Granted :

Nill

Specify National/International :

Nill

Number Of Patents Applied For :

Nill

Specify National/International :

Nill

PRESENTATIONS IN CONFERENCES AS SPEAKER/ RESOURCE PERSON

Number Of Presentations In National Or International Conferences In India :

69

Please Specify Invited/Oral/Poster :
  1. Invited to attend the Silver Jubilee function of National Pharmaceutical Pricing Authority on 29th August, 2022, in New Delhi.
  2. Attended the Seminar on Research Ecosystem in Higher Education Institutions and its Impact on Accreditation and Ranking organized by Jamia Hamdard held on August 01, 2022. 
  3. Attended the 12th Indian Association for the Study of Traditional Asian Medicine (IASTAM)  “International Conclave on Multi-targeted therapeutics in Unani and Ayurvedic Medicine & Food Supplement”  Organized by Centre of Excellence in Unani Medicine (Pharmacognosy and Pharmacology), School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi held on  July 29-30, 2022.

 

  1. Attended XII Annual virtual Conference of Global Indian Physicians Congrees (GAPIO) organized by the West Bengal Medical Council, from 26-27 February, 2022.
  2. Attended DST-II India Netherlands Technology Summit from 15th -16th Oct. 2019, New Delhi at Hotel J W Marriott, Aerocity, New Delhi.  
  3. Attended a National Conference on Alternatives to Animal Experiments (NCAAE-2018) held at Jamia Hamdard, New Delhi on November 27, 2018.
  4.  Attended Annual CME of Delhi Chapter – ISAR entitled “Atherosclerosis - The Indian Epidemic’’ organized by Indian Society of Atherosclerosis Research – Delhi Chapter (ISAR-DC) & Department of Biochemistry, Sir Ganga Ram Hospital, New Delhi on 26th September 2018.
  5.   Attended National Workshop on Good Laboratory Practice (GLP) at Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana, organized by Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA) , Deptt. Of Science and Technology, Government of India on 24th September 2018.
  6. Attended Conference-cum-Workshop on Molecular Imaging & Drug Delivery, held on 26th -27th March, 2018 in Jamia Hamdard.
  7.  Attended One Day National Symposium on Research Methodology, held on 7th March, 2018 in the School Auditorium, SPER, Jamia Hamdard.
  8. Attended 12th FICCI HIGHER EDUCATION SUMMIT 2016 Global Conference & Exhibition held in Vigyan Bhavan, New Delhi on 10–12th   November 2016, with a Pre-Conference Workshop & Master Classes at the Federation House, on FICCI on 9th November, 2016.
  9. Contributed as an Organizing Committee Member in conducting ISARCON-2015, 28th Annual Conference on “Indian Society for Atherosclerosis Research & CME- New Paradigms in Atherosclerosis & Cardio-vascular Disorders” organized by Hamdard Institute of Medical Sciences & Research (HIMSR), Hamdard University, New Delhi (29-31 October, 2015)
  10. Attended  Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers Govt of India sponsored National Conference on “PAT and QbD-The Enablers of Pharmaceutical Quality” organized by Faculty of Pharmacy, Hamdard University(Jamia Hamdard),New Delhi(17th March,2016)
  11. Attended  Ministry of Chemicals and Fertilizers Govt of India sponsored National Seminar  on “REASSESSING THE BASIC ELEMENTS OF QUALITY ASSURANCE FOR PHARMACEUTICAL PERFORMANCE USING ICH Q10 GUIDELINES” organized by Faculty of Pharmacy, Hamdard University(Jamia Hamdard),New Delhi(18th March,2016)
  12. Attended two days training programme on (Leadership And Personality Enrichment Program for Faculty) organized by IQAC, Jamia Hamdard University, New Delhi, (September 26-27, 2014).
  13. Attended ‘UGC SAP sponsored National Conference on Chronic Inflammatory Disorders’ organized by Hamdard University (Jamia Hamdard), New Delhi, (13-15 Feb., 2014)
  14. Attended one day seminar on ‘Surface Analytical Techniques’ organized by Indian Society of Analytical Scientist (ISAS)-Delhi Chapter in association with M/s Shimadzu at Hotel Comfort Inn, Faridabad. (24th August, 2013).
  15. Attended ‘National Seminar on Medicinal Plants and their Characterization’ organized by Department of Botany, Hamdard University, New Delhi (26-27 February, 2013)
  16. Attended UGC Sponsored National Conference on ‘Bioelectronics & Biomedical Technology’ organized by Department of Biochemistry, Hamdard University, New Delhi (29-30 January, 2013).
  17. Participated in ‘Poster Presentation’ entitled ‘Integration of traditional medicines into healthcare system in India’ on Universal Healthcare at Annual Healthcare Conference ‘FICCI HEAL 2012’ organized by Federation of Indian Chambers of Commerce and Industry (FICCI), New Delhi (27-29 August, 2012).
  18. International Congress on Advances in Human Healthcare Systems ‘Healthcare India 2012’ organized by Asian Polymer Association (APA) in association with Hamdard University, New Delhi and Indian Institute of Technology (IIT), Delhi (February 20-23, 2012: Oral Presentation).
  19. Attended AICTE sponsored National Seminar on “New Horizones in Drug Discovery and Developments” organized by the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi (17-18 September, 2011) 
  20. Attended “Life Science Conclave 2011” organized by Confederation of Indian Industry in association with Department of Science and Technology (DST), Department of Biotechnology (DBT), Department of AYUSH, Quality Council of India (QCI), National Research Development Corporation (NRDC) and Indian Council for Medical Research (ICMR), held at New Delhi (29-30 August 2011).
  21. International Conference and CME cum Workshop on Pharmacovigilance Systems and Rational Use of Drugs: An Integrated Approach (“Vision for Sustainable Pharmacovigilance in India”) organized by Deptt. of Pharmacology, Lady Hardinge Medical College, New Delhi (26-28 November, 2010).
  22. 2nd Biennial International Conference on “New Developments in Drug Discovery from Natural Products and Traditional Medicines” organized by the Department of Natural Products at National Institute of Pharmaceutical Education and Research (NIPER), Punjab (20-24 November, 2010: Oral Presentation).
  23. National Seminar on “Recent Trends in Pharmacy Education and Practice” conducted by Pharmacy Council of India (PCI) at Vigyan Bhavan, New Delhi (July 9-10, 2010).
  24. Participated in “Summer School Cutting Edge Technologies in the Life Sciences” in Hamdard University, New Delhi (15 June, 2010 to 30 June, 2010).
  25. International Conference on “Recent Advances in Cardiovascular Sciences” at Delhi Pharmaceutical Sciences and Research University, New Delhi (3rd & 4th February, 2010).
  26. 54th Annual National Conference of Association of Physiologists and Pharmacologists of India (APPICON-2009) at Saifai, Etawah (U.P.) (December 3-6, 2009: Oral Presentation).
  27. National Conference on ‘Medical Devices’ Moving up the value chain sponsored by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, at Federation House, FICCI, New Delhi (8th October, 2009).
  28. International Seminar on ‘Centenary Celebration of All India Ayurvedic Congress’, SIRI Fort Auditorium, New Delhi, India, sponsored by Department of Ayush, Ministry of Health and Family Welfare, Government of India (attended only on 7th October, 2009).
  29. Workshop for the Inspectors of the Pharmacy Council of India (PCI) at Indian National Science Academy (INSA), New Delhi (5th October, 2009) (Ref. No. 14-133/2009-PCI; 14-18/2005-PCI/17424-578 dated 11September, 2009).
  30. AICTE sponsored National Seminar on ‘Emerging Trends in Pharmaceutical Sciences’, Hamdard University, New Delhi (21-22 March, 2009).
  31. Seminar on ‘Intellectual Property Rights Protection & Management’ organized by the National Research Development Corporation in collaboration with Central Council for Research in Unani Medicine (CCRUM), Hamdard University, New Delhi (11-12 February, 2009).
  32. International Conference on Translational Pharmacology & 41st Annual Conference of Indian Pharmacological Society (IPS), AIIMS, New Delhi (18-20 December, 2008).
  33. 60th Indian Pharmaceutical Congress (IPC), New Delhi (12-14 December, 2008).
  34.  Workshop on “Real Time PCR”, Hamdard University, New Delhi (26-27 December,   2007).
  35. 59th Indian Pharmaceutical Congress (IPC), Varanasi, U.P. (20-23 December, 2007).
  36. One day Seminar on “Syntheses and Characterization of Nanomaterials” by Society of Analytical Chemists, Jamia Hamdard, New Delhi (17th November, 2007).
  37. International Conference on Research Advances in Traditional Medicine: Challenges and Opportunities, Jamia Hamdard, New Delhi, India (30-31st October, 2007).
  38. One day Interactive session on “Putting Herbals Centre Stage: Pharmacopeial Initiative organized by Indian Pharmaceutical Association, Delhi Branch and Indian Pharmacopeial Commission, New Delhi (1st September, 2007). 
  39. National Symposium on “Awareness, Preparedness and Mitigation of Exposure to Domestic and Industrial Chemicals (EPMEDIC-2007)”, New Delhi (30-31st August, 2007).
  40. Workshop on “Rheumatoid Arthritis” organized by Central Council for Research in Unani Medicine, Ministry of Health, New Delhi (27-28th August, 2007).
  41. Workshop on “Herbal Insect Repellants: New Developments”, New Delhi (24th June, 2007).
  42. Annual Conference of the Indian Society of Hypertension & International Symposium on Atherosclerosis in Hypertension, Diabetes and Coronary Artery Disease (BPCON 2007), CDRI, Lucknow, India (15-16 March, 2007).
  43. 39th Annual Conference of the Indian Pharmacological Society (IPS), Jaipur, Rajasthan, India (21-23 December, 2006).
  44. International Symposium on “Herbal Drug Research and Therapy”, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India (09-10th December, 2006).
  45. National Seminar on Medicinal Plants: Conservation, cultivation and utilization, Gurukul Kangri Vishwavidyalaya, Haridwar, Uttranchal, India (9-11 March, 2006).
  46. 3rd North Zone Conference of Indian Pharmacological Society, New Delhi, India (23 April, 2005).
  47. Seminar on” Intellectual Property Rights Awareness in Pharmaceuticals” Hamdard University, New Delhi, India (26 Feb, 2005).
  48. International Conference on Unani Medicine, New Delhi, India (8-11 Feb, 2005).
  49. International Workshop on Adverse Drug Reaction Monitoring & 4th Annual Conference of Pharmacovigilance Society of India, Bareilly, UP, India (Jan 22-23, 2005).
  50. Joint International Conference of International Society for Heart Research (Indian Section) & International Academy of Cardiovascular Sciences (India Section), Ahmedabad, India (Dec. 31-Jan2, 2005).
  51. Indo-UK Seminar on Biomarkers of Ecotoxicity, Cancer, Monitoring and Prevention, Jamia Hamdard, New Delhi (29 Aug, 2004).
  52. International Symposium on Recent Advances in Pharmacology, New Delhi India (7-8 Jan, 2004).
  53. 36th Annual Conference of Indian Pharmacological Society, Delhi, New India (5-7, Dec., 2003).
  54. Update on Newer Drug Development for HIV/ AIDS and in Ocular  Pharmacology, AIIMS, New Delhi (7th Sept, 2003).
  55. Symposium on Poison Information Network in India (NPIC-2001), AIIMS, New Delhi (17-19 Dec., 2001).
  56. Symposium on Challenges in Clinical Pharmacology, Vallabhbhai Patel Chest Institute, Univ of Delhi, Delhi, (10th Nov. 2001).
  57. Annual conference of International Society for Heart Research (Indian Section), AIIMS, New Delhi (22-29 Jan., 2001).
  58. 5th Annual Convention of Association of Pharmaceutical Teachers of India (ATPI), Udaipur, Rajasthan (4-5 Sep., 2000).
  59. International Congress on Frontiers in Pharmacology and Therapeutics in 21st Century, New Delhi, India (1-4 Dec. 1999).
  60. International Symposium on New Drug Development, (Feb. 6-8, 1998), New Delhi, India.
  61. International Seminar on "Recent trends in Pharmaceutical Sciences", Ootacamund, Tamil Nadu, India (18-20 Feb. 1995).
  62. 27th Annual Conference of Indian Pharmacological Society, Bombay, India (21-24 Dec. 1994).
  63. 26th Annual Conference of Indian Pharmacological Society, Hisar, Haryana, India (25-27 Nov. 1993).
  64. Update on Clinical Ocular Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India (23rd Nov. 1993).
  65. 21st Annual Conference of Indian Pharmacological Society, Hyderabad, India (29-31 Dec., 1988).
  66. 39th Indian Pharmaceutical Congress Madras, India (1-3 Jan., 1988).
Number Of Presentations In International Conferences Abroad :

12

Please Specify Invited/Oral/Poster :
  1. Virtual Presentation in a Science at a Glance (SaaG Poster Session) in an international Conference, 88th European Atherosclerosis Society (EAS), 2020 (Geneva Switzerland), from Oct. 04-07-2020 (Virtual Congress).
  2. Oral presentation in an International Conference on Disease Biomarkers and Precision Medicne organized by United Scientific Group at Houston (USG), TX 77032 USA from October 22-24, 2018 and presented the paper entitled ‘ Diagnostic Evaluation of Various Biomarkers in Non Alcoholic Fatty Liver Disease’.
  3. Poster presentation in XVIII International Symposium on Atherosclerosis (ISA 2018) organised by International Atherosclerosis Society at Toronto, Ontario, Canada, June 10-12, 2018 and the poster entitled’ Effect of embelin in Monosodium Glutamate Induced Obesity in Neonatal Wistar Rats’.
  4. Oral presentation in 2nd International Conference on Obesity and Chronic Diseases(ICOCD-2017) at San Francisco, CA, USA, July 06-08, 2017 and presentated the paper entitled ‘Antiobesity potential of Embelin in high fat diet-induced obesity in Wistar rats’.
  5. 2nd World Congress on Targeting Microbiota, 2014, ‘ Embelin suppresses gut microbiota – induced proatherosclerotic  metabolite , Trimethylamine –N-Oxide (TMAO) level in choline fed Wistar rats’. (Poster Presentation)  Paris, France, Oct. 16-17, 2014.
  6. 81 European Atherosclerosis Society (EAS) Congress Lyon, France (2-5 June, 2013) Attended Gordon Research Conference on Lipoprotein Metabolism at Waterville Valley, New Hampshire, USA (17-22 June, 2012).
  7. 3rd International Symposium on Pharmacology of Natural products (FAPRONARURA 2012), Havana, Cuba (6-10 June, 2012) and presented the paper (Plenary Lecture) entitled ‘Association of cardiomyocyte apoptosis with metabolic syndrome in type 2 diabetic rats with obesity: potential of Gymnemic Acid-Phospholipid Complex (GPC)’.
  8. 79th European Atherosclerosis Society (EAS) Congress, Gothenburg, Sweden (26-29 June,      2011) and presented the paper entitled ‘Molecular insights into cardiomyocyte apoptosis:  Treatment with pioglitazone in low-dose streptozotocin and high fat diet fed obesity in murine model (Poster No. 3.39)’ Atherosclerosis [Supplement], 2011, 12 (1): 106.
  9. Obesity 2010, 28th Annual Scientific Meeting, San Diego, USA (8-12 October, 2010) and presented the paper entitled ‘Preventing Cellular Obesity Changes and Target Organ Damage: The Heart by Ethanolic Gymnema sylvestre in Murine Model of Obesity (745-P)’. Obesity supplement, 2010, Volume 18.
  10. XV World Congress of Pharmacology (IUPHAR), Beijing, CHINA (2-7 July 2006) and presented the paper entitled ‘Blood Pressure Lowering & Antioxidant Potential of Aqueous Extract of Embelia ribes in Diabetic Rats (P280008)’ Acta Pharmacologica Sinica (Supplement), 2006, 1:297.
  11. XIV World Congress of Pharmacology (IUPHAR), San Francisco, USA (7-12 July 2002)

     and presented paper entitled ‘Prevention of diabetic dyslipidemia by Embelia ribes and

     Ocimum sanctum in streptozotocin-induced diabetic rats.

12.   XIIIth International Congress of Pharmacology (IUPHAR), Munchen, Germany (26-31 July, 1998) and presented paper entitled ‘Prevention and reduction of hypercholesterolemia by Zingiber officinale in rabbits on atherogenic diet (P 51.16)’

NATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

1. National Achiever of the Year, 2023

2. Distinguised Researcher Award

3. Best Academician of the Year 2022 

4. Certificate of Appreciation and incentive

5. Shiksha Rattan Puraskar 

6. Certificate of Recognition’ and an amount of Rs.5000/- awarded

7.  Scientist of the Year Award 

8.  award and medal for securing Ist position in M. Pharma (Pharmacology), 

 

ICMR-Research Associate Fellowship: One

Title: To investigate the potential of saroglitazar against monosodium glutamate –induced obesity and associated comorbidities in Wistar rats.

Candidate: Sayima Nabi, Fellowship awarded in March, 2022.

JAMIA HAMDARD SILVER JUBILEE FELLOWSHIP: One

  1. Title: Evaluation of antiobesity potential of Saroglitazar in monosodium glutamate 

obese neonatalWistar rats.

Candidate: Sayima Nabi, Fellowship awarded in Oct, 2018

HAMDARD NATIONAL FOUNDATION FELLOWSHIP (HNF): Two

  1. Title: Assessment of the potential of anti- PCSK9 monoclonal antibody (mAb1)

and atorvastatin alone and in combination in murine model of atherogenesis and

  • .

Candidate: Priyanka Arya Fellowship awarded in April 2019- March 2020 & Sep,

  1.  
  1. Title: Evaluation of antiobesity potential of Saroglitazar in monosodium glutamate 

obese neonatalWistar rats.

Candidate: Sayima Nabi, Fellowship awarded in Sep, 2021.

 

 

UGC NET ASSISTANT PROFESSORSHIP: Two

  1. Title: Effect of embelin in metabolic endotoxemia mediated- inflammation & associated obesity induced by high fat diet in C57BL/6 mice.

Candidate: Priyanka Bansal, Qualified in July, 2018

  1. Title Assessment of the potential of anti- PCSK9 monoclonal antibody (mAb1)and atorvastatin alone and in combination in murine model of atherogenesis 

Candidate: Priyanka Arya, Qualified in June, 2019

Granting Agency :

1. Centre for Education Growth and Research (CEGR) 

2. Centre for Women Development,Venus International Foundation,

3. Centre for Education Growth and Research (CEGR) 

4. Jamia Hamdard 

5. Certificate of Excellance by India International Friendship Society, New Delhi, India 

6. Jania Hamdard  

7. National Environmental Science Academy, New Delhi

8. Indian Pharmaceutical Association (IPA)

 

Year Of Award :

1. 2023

2. 2023

3. 2022

4. 2016

5.  2012

6. 2011

7. 2007

8. 1988

INTERNATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

1. Travel GRANT AWARD

2. ICMR Travel Grant Award 

3. Nature Travel Grant 

4. INSA Delegate travel grant 

5. US Travel Grant Award 

6. (Category 1) of travel grant 

Granting Agency :

1. Jamia Hamdard 

2. ICMR 

3. Nature Publishing Group (NPG, USA office) 

4. Indian National Science Academy (INSA)

5. IUPHAR (International Union of Pharmacology)

6. Indian National Science Academy (INSA)

Year Of Award :

1. 2018

2.2012

3. 2012

4. 2006

5. 2002

6. 1998

STAFF DEVELOPMENT/REFRESHER/SHORT TERM TRAINING PROGRAMME/WEBINARS ORGANIZED

Title :

 

  1. As Chairperson, Women Development Cell, Organised Health camp in Jamia Hamdard       
             Camp in collaboration with Titan Eye Plus on 18th Feb 2025
  2. Organised the International Women’s day celebration as Chairperson, Women Development Cell on 8th March 2024, in Jamia Hamdard, New Delhi.
  3. Organised Free Eye Camp in collaboration with Titan Eye Plus, as Chairperson, Women Development Cell on 5th March 2024, in Jamia Hamdard, New Delhi.
  4. ‘UGC SAP sponsored National Conference on Chronic Inflammatory Disorders’ organized by Hamdard University (Jamia Hamdard), New Delhi, (13-15 Feb., 2014)

Duration :

Sponsoring Agency :

MEMBER(S) OF NATIONALCOMMITTEES

  1. Member of International Science Council, USA since 2020
  2. Nominee, CPCSEA, Ministry of Environment, Govt. of India w.e.f. Jan., 2014
  3. Life Member, Asian Polymer Association (No.L324) since Jan, 2012.
  4. Life Member, The Indian Society for Atherosclerosis Research (LM-331) (w.e.f. Sept, 2011).
  5. European Atherosclerosis Society (No.3233), 2009,2010, 2012, 2019
  6. Member, Obesity Society, USA (2010)
  7. Member, New York Academy of Sciences, USA, 2003.
  8. Member, American Diabetes Association, USA, 2000, 2001.
  9. Life Member, National Environmental Science Academy.
  10. Life Member, Indian Society of Analytical Scientist.
  11. Life Member, Indian Society of Hypertension.
  12. Life Member, Indian Society of Pharmacovigilance.
  13. Life Member, Indian Society of Heart Research (ISHR).
  14. Life Member, Indian Society for Technical Education (ISTE).
  15. Life Member, Indian Pharmacological Society (IPS).
  16. Life Member, Indian Toxicological Society (ITS).
  17. Life Member, Association of Pharmaceutical Teachers of India (APTI).

MEMBER(S) OF INTERNATIONAL COMMITTEES

  1. Member of International Science Council, USA since 2020
  2. Nominee, CPCSEA, Ministry of Environment, Govt. of India w.e.f. Jan., 2014
  3. Life Member, Asian Polymer Association (No.L324) since Jan, 2012.
  4. Life Member, The Indian Society for Atherosclerosis Research (LM-331) (w.e.f. Sept, 2011).
  5. European Atherosclerosis Society (No.3233), 2009,2010, 2012, 2019
  6. Member, Obesity Society, USA (2010)
  7. Member, New York Academy of Sciences, USA, 2003.
  8. Member, American Diabetes Association, USA, 2000, 2001.
  9. Life Member, National Environmental Science Academy.
  10. Life Member, Indian Society of Analytical Scientist.
  11. Life Member, Indian Society of Hypertension.
  12. Life Member, Indian Society of Pharmacovigilance.
  13. Life Member, Indian Society of Heart Research (ISHR).
  14. Life Member, Indian Society for Technical Education (ISTE).
  15. Life Member, Indian Pharmacological Society (IPS).
  16. Life Member, Indian Toxicological Society (ITS).
  17. Life Member, Association of Pharmaceutical Teachers of India (APTI).

ADMINISTARTIVE RESPONSIBILITIES/ PARTICIPATION IN COMMITTEES OF JAMIA HAMDARD

 

1.Appointed as Officiating Dean of School of Pharmaceutical Education and Research  by Vice Chancellor from, Jamia Hamdard 

2. Appointed as Officiating Head of Department of Pharmacology, School of Pharmaceutical  Education and Research  by  Vice Chancellor from, Jamia Hamdard 

3. Appointed as Chancellor Nominee for Selection Committee for CAS promotion from Assistant Professor (Stage-3) to Associate Professor (Stage-4) for the subject of Statistics (Re-assessment case) in the School of Pharmaceutical Education and Research  (SPER),

4. Appointed as Chairman of Scientific committee in 27th Convention of Indian Society of Pharmacognosy and International Conference “Role of Traditional Medicine and Phytopharmaceuticals in Health Care for Viksit Bharat”, Jamia Hamdard, 4th and 5th October, 2024.Jamia Hamdard. Interview held on 25-11-2024.

5. Appointed as Chairperson, Women Development Cell, by competent authority, Jamia Hamdard for a period of two years on 05-01-2024.

6. Appointed as VC Nominee to be part of the Panel for  interviews  for the shortlisted PhD Candidates of (Cycle I), Session 2023-24  for the School of Interdisciplinary Sciences and Technology (SIST) by Competent authority of Jamia Hamdard  on 07-12-2023

7. VC Nominee for the selection committee as an Expert Member in the panel of the Examiners for conducting the interview for the selection of SRF in the ICMR project of Prof. Suhel Parvez, SCLS, Jamia Hamdard on 21-06-2023.

8. Member, allocation of Supervisors to M Pharm (Pharmacology and Pharmacy Practice) Candidates, in the meeting held on 22-07-2022.

9. ‘Team leader’, Flying Squad Team for annual/End examination -2022 in various  Schools  (SPER; Department of Management, Department of Paramedical Sciences, Department of Media and Mass Communication, Department of Computer Science and Engineering) as approved by Competent Authority on 27th July, 2022.

10. Member of Board of study of the Department 

 

ANY OTHER

 

  1. Nominated member of American Biographical Institute's Professional Women’s Advisory Board since 2004.
  2. Set up Pharmacy Department in the Capacity of Director (Founder), Pharmacy, IIMT, College of Medical Sciences, Meerut Affiliated to U.P. Technical University, Lucknow, U.P. in the pay scale of Rs. 20,400-500-Rs. 22,400 after availing one year extra-ordinary leave from Hamdard University; from 11-07-2005 to 10-07-2006.
  3. Inclusion in the Panel of Inspectors of Pharmacy Council of India (PCI) [Ref. No. 1-2//2006Pt.I-PCI-6692-822, dated 25th June, 2007].
  4. Visited Central Research Institute (Ayurveda), Gwalior, Madhya Pradesh in connection with setting up Pharmacy and Pharmacological Laboratories of the Institute (30 and 31st October, 2006).
  5. Nominated as Member by DG, ICMR, Project Review Committee of Indian Council of Medical research (ICMR), New Delhi in the subject of Pharmacology w.e.f May, 2012. (Ref. No 58/48/2011-BMS, dated 18/05/2012)
  6. ‘Internal Examiner’ for evaluation of thesis and viva-voce for M.Pharma IV Semester examination (MPG-401) in the Department of Pharmacology, SPER, Jamia Hamdard.
  7. Subject Expert for the Selection Committee meeting for the Pharmaceutical Sciences by PDM University ,Haryana held on 8th August 2017
  8. External Examiner’ for setting of the question paper of the M.Pharma Pharmacology in the subject, Advanced Pharmacology (MPL-102T) in Jamia Hamdard, New  Delhi,  in Oct. 2018.
  9. External Examiner’ for setting of the question paper of the M.Pharma (Pharmacology/Pharmaceutics) in the subject, Research Methodology and Statistics (MPL-301T & MPH-301T) in BB Ambedkar University, Lucknow in Nov. 2018. 
  10. Member, Institiutional ANIMAL Ethics Committee Meeting (I
  11. Attended as an Expert member  (CPCSEA Nominee) in Institutional Animal Ethics Committee (IAEC) meeting held in INMAS, DRDO on 10th June, 2019.
  12. As Organizing Secretary, conducted UGC-SAP DRS-II Sponsored Seminar on Recent Advances in Pharmacotherapeutics on 28th March, 2019, SPER, Jamia Hamdard.
  13. Appointed as an Expert to evaluate the proposals received for National Research Development Corporation (NRDC) National Meritorious Invention Awards Programme in Sept, 2019.
  14. Attended as an Expert in Union Public Selection Commission (UPSC) Interview Board for the interview of Scientific Officer (Pharmacology) held in UPSC, New Delhi on 12th June, 2019.
  15. Appointed as an Examiner for setting of question paper and evaluation of answer books of Ph.D. course work in Cardiovascular Pharmacology (PhD PCOL 103) by the Jamia Hamdard in August 2019.
  16. Appointed as Expert on 16th Sept. 2019 for evaluating the proposal received for National Research Development Corporation (NRDC) on behalf of DSIR, New Delhi.
  17. External Examiner to evaluate the Ph.D. thesis of Ph.D. candidate from Panjab University, Chandigarh, India in Sept. 2019.
  18. Empanelled with Tata Consultancy Services (TCS iON) as a Subject Matter Expert for Pharmacology in January 2021.
  19. Attended as an Expert in Union Public Selection Commission (UPSC) Interview for the insitu promotion of Scientists of Central Drug Laboratory of Kolkata, W.B. held in UPSC, New Delhi on 29 Dec 2020 IAEC), INMAS, 11th April,2018
  20. NAAC Assessor : Nominated by NAAC ( National Assessment and Accreditation Council) of UGC, Govt. of India 
  21. As an External Examiner to evaluate the Ph.D. thesis of Ph.D. candidate from Deptt. of Pharmaceutical Sciences, Amity Institute of Pharmacy, Amity University, Uttar Pradesh, India in February, 2022.
  22. Appointed as Internal Examiner for the B.Pharm Semester VII (Regular & SFS) Examination of the Subject of Practice School (BP 706PS) by  Jamia Hamdard in January, 2022.
  23. Appointed as an Examiner for setting of question paper  of Ph.D. Course Work of the Subject Basic Pharmacology (PhD PCOL 102) by the Jamia Hamdard in August, 2022.
  24. Member, allocation of Supervisors to M Pharm (Pharmacology and Pharmacy Practice) Candidates, in the meeting held on 22-07-2022.

Uma Bhandari

Email : ubhandari@jamiahamdard.ac.in

View Google Scholar

PERSONAL INFORMATION

Alternate Email :

uma_bora@hotmail.com

Designation :

Professor

Department & School :

Department of Pharmacology & School of Pharmaceutical Education and Research (SPER)

Qualifications :

Phd in Pharmacy University of Delhi, M.Pharm University of Delhi, B.Pharma Univeristy of Delhi

State Of Domicile :

Delhi

Research Thrust Areas :

Cardio Metabolic Disorders including atherosclerosis, obesity, diabetes

Details Of Courses Taught

M.Pharm (Pharmacology), B.Pharma, D.Pharma , General Pharmacology, Chemotherapy and Practicals in Pharmacology in Medical colleges

PUBLICATIONS

BOOKS & BOOK CHAPTERS PUBLISHED

Number Of Books Published By National Publisher :

  1. A Textbook of Pharmacology.2011, Biotech Pharma Publications, Chennai, India     (ISBN: 978-93- 80682- 02-0).
  2. Introduction to Experimental Pharmacology. 2010, 1st edition, Birla Publications, Delhi, India (ISBN: 818974789-4).
  3. A Text book of Pharmacology for B. Pharma, 1998, Piyush Publications, Delhi, India (ISBN: 81-86548-02-7)
  4. Pharmacology & Toxicology by Uma Bhandari & Shamim Ahmed, 1995, Piyush Publications, Delhi, India (ISBN:81-86548-21-1)

The Name Of The Publisher :

1. Biotech Pharma Publications, Chennai, India   

2. Birla Publications, Delhi, India 

3.  Piyush Publications, Delhi, India

4.  Piyush Publications, Delhi, India

Number Of Books Published By International Publisher :

Nill

The Name Of The International Publisher :

Nill

Number Of Book Chapters In Edited Books Of National Publishers :

Nill

The Name Of The Publisher:

Nill

Number Of Book Chapters In Edited Books Of International Publishers :

Nill

The Name Of The Publisher :

Nill

RESEARCH GRANTS AND CONSULTANCY PROJECTS

Number Of Research Grants From Govt. Funding Agencies As PI/Coordinator :

S. No.

Investigator

Title of the Project

Funding Body

Funds Sanctioned / Applied for

1.

Principal Investigator

(3 years Major Research Project: 2015-2018) (UGC)

Project is sanctioned on 26.12.2014

Study of gut microbiota-induced atherosclerosis and obesity and modulation by Embelin in rats

University Grants Commission (UGC)

Candidate ID: MRP-MAJOR-PHAR-2013-39022

Interview held on 24.12.2014

Results were declared on 26.12.2014

Rs. 13,52,000/-

2.

Principal Investigator

(3 years Major Research Project: 2004-2007)

Pharmacological Investigations of Embelia ribes for cardioprotective and antioxidant activities in models of oxidative stress in diabetic rats

(Major Research Project)

UGC

F. no.: F-12/2004/SR;

Dated. 29-12-2003, from 1-4-2004 to 31-3-2007. 

 

Rs. 8,37,000/-

3.

Principal Investigator

(2 years Major Research Project : 2007-2009)

To Evaluate the Effect of Embelia ribes Extracts on Myocardial Infarction & Cerebral Ischemia in Models of Oxidative Stress in Rats

F. no.: 8023/BOR/RPS-

156/2006-07, dated:  February 26, 2007 All India Council of Technical Education (AICTE)

 

 

Period: April, 2007 –

March, 2009

 

Rs. 6.9 Lakhs

4.

Principal Investigator

(3 years Major Research Project: 2008-2011)

Evaluation of Gymnema sylvestre extract (gurmar) for antiobesity activity in normal and diabetic albino rats

UGC

F. No. 33-117/2007(SR), Dated: 28th February, 2008

 

Period: April, 2008 – March, 2011

 

Rs. 10,76,800/-

5.

Principal Investigator

(3 years Major Research Project: 2009-2012)

Pharmacological investigation on Embelia ribes (Vidanga) for antiobesity activity in rats

Central Council of Research in Ayurveda & Siddha (CCRAS), Department of Ayush, Ministry of Health

F. No. 5-29/2006/CCRAS/ Teck/Hq/EMR,

Dated: 04/10/2007

F.No.Z.31014/02/2009/EMR-CCRAS dated 21/08/2009

 

 

Rs. 15,32,000/-

Name Of The Agency And Amount Of Funding Generated :

1. University Grants Commission (UGC) Ammount: Rs. 13,52,000/- 

2. University Grants Commission (UGC) Ammount: Rs. 8,37,000/-

3. All India Council of Technical Education (AICTE) Ammount: Rs. 6.9 Lakhs

4. University Grants Commission (UGC) Ammount: Rs. 10,76,800/-

5. Central Council of Research in Ayurveda & Siddha (CCRAS), Department of Ayush, Ministry of Health Ammount: Rs. 15,32,000/-

6.  University Grants Commission (UGC) Ammount:Rs. 16,000/-

Number Of Research Grants From Govt. Funding Agencies As Co-PI :

Nill

Name Of The Agency And Amount Of Funding Generated :

Nill

Number Of Research Grants From International And Private Sources As PI :

Nill

Name Of The Agency And Amount Of Funding Generated :

Number Of Consultancy Projects :

Nill

Name Of The Agency And Amount Of Funding Generated :

Nill

RESEARCH SUPERVISION

Number Of Master’s Theses/DissertationsGuided :

46


Number Of Ph.D. Guided :

16

Number Of Master’s Theses/DissertationsGuided :

Nill

Number Of Co-supervisorPhd :

3

PATENTS

Number Of Patents Granted :

Nill

Specify National/International :

Nill

Number Of Patents Applied For :

Nill

Specify National/International :

Nill

PRESENTATIONS IN CONFERENCES AS SPEAKER/ RESOURCE PERSON

Number Of Presentations In National Or International Conferences In India :

69

Please Specify Invited/Oral/Poster :
  1. Invited to attend the Silver Jubilee function of National Pharmaceutical Pricing Authority on 29th August, 2022, in New Delhi.
  2. Attended the Seminar on Research Ecosystem in Higher Education Institutions and its Impact on Accreditation and Ranking organized by Jamia Hamdard held on August 01, 2022. 
  3. Attended the 12th Indian Association for the Study of Traditional Asian Medicine (IASTAM)  “International Conclave on Multi-targeted therapeutics in Unani and Ayurvedic Medicine & Food Supplement”  Organized by Centre of Excellence in Unani Medicine (Pharmacognosy and Pharmacology), School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi held on  July 29-30, 2022.

 

  1. Attended XII Annual virtual Conference of Global Indian Physicians Congrees (GAPIO) organized by the West Bengal Medical Council, from 26-27 February, 2022.
  2. Attended DST-II India Netherlands Technology Summit from 15th -16th Oct. 2019, New Delhi at Hotel J W Marriott, Aerocity, New Delhi.  
  3. Attended a National Conference on Alternatives to Animal Experiments (NCAAE-2018) held at Jamia Hamdard, New Delhi on November 27, 2018.
  4.  Attended Annual CME of Delhi Chapter – ISAR entitled “Atherosclerosis - The Indian Epidemic’’ organized by Indian Society of Atherosclerosis Research – Delhi Chapter (ISAR-DC) & Department of Biochemistry, Sir Ganga Ram Hospital, New Delhi on 26th September 2018.
  5.   Attended National Workshop on Good Laboratory Practice (GLP) at Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana, organized by Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA) , Deptt. Of Science and Technology, Government of India on 24th September 2018.
  6. Attended Conference-cum-Workshop on Molecular Imaging & Drug Delivery, held on 26th -27th March, 2018 in Jamia Hamdard.
  7.  Attended One Day National Symposium on Research Methodology, held on 7th March, 2018 in the School Auditorium, SPER, Jamia Hamdard.
  8. Attended 12th FICCI HIGHER EDUCATION SUMMIT 2016 Global Conference & Exhibition held in Vigyan Bhavan, New Delhi on 10–12th   November 2016, with a Pre-Conference Workshop & Master Classes at the Federation House, on FICCI on 9th November, 2016.
  9. Contributed as an Organizing Committee Member in conducting ISARCON-2015, 28th Annual Conference on “Indian Society for Atherosclerosis Research & CME- New Paradigms in Atherosclerosis & Cardio-vascular Disorders” organized by Hamdard Institute of Medical Sciences & Research (HIMSR), Hamdard University, New Delhi (29-31 October, 2015)
  10. Attended  Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers Govt of India sponsored National Conference on “PAT and QbD-The Enablers of Pharmaceutical Quality” organized by Faculty of Pharmacy, Hamdard University(Jamia Hamdard),New Delhi(17th March,2016)
  11. Attended  Ministry of Chemicals and Fertilizers Govt of India sponsored National Seminar  on “REASSESSING THE BASIC ELEMENTS OF QUALITY ASSURANCE FOR PHARMACEUTICAL PERFORMANCE USING ICH Q10 GUIDELINES” organized by Faculty of Pharmacy, Hamdard University(Jamia Hamdard),New Delhi(18th March,2016)
  12. Attended two days training programme on (Leadership And Personality Enrichment Program for Faculty) organized by IQAC, Jamia Hamdard University, New Delhi, (September 26-27, 2014).
  13. Attended ‘UGC SAP sponsored National Conference on Chronic Inflammatory Disorders’ organized by Hamdard University (Jamia Hamdard), New Delhi, (13-15 Feb., 2014)
  14. Attended one day seminar on ‘Surface Analytical Techniques’ organized by Indian Society of Analytical Scientist (ISAS)-Delhi Chapter in association with M/s Shimadzu at Hotel Comfort Inn, Faridabad. (24th August, 2013).
  15. Attended ‘National Seminar on Medicinal Plants and their Characterization’ organized by Department of Botany, Hamdard University, New Delhi (26-27 February, 2013)
  16. Attended UGC Sponsored National Conference on ‘Bioelectronics & Biomedical Technology’ organized by Department of Biochemistry, Hamdard University, New Delhi (29-30 January, 2013).
  17. Participated in ‘Poster Presentation’ entitled ‘Integration of traditional medicines into healthcare system in India’ on Universal Healthcare at Annual Healthcare Conference ‘FICCI HEAL 2012’ organized by Federation of Indian Chambers of Commerce and Industry (FICCI), New Delhi (27-29 August, 2012).
  18. International Congress on Advances in Human Healthcare Systems ‘Healthcare India 2012’ organized by Asian Polymer Association (APA) in association with Hamdard University, New Delhi and Indian Institute of Technology (IIT), Delhi (February 20-23, 2012: Oral Presentation).
  19. Attended AICTE sponsored National Seminar on “New Horizones in Drug Discovery and Developments” organized by the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi (17-18 September, 2011) 
  20. Attended “Life Science Conclave 2011” organized by Confederation of Indian Industry in association with Department of Science and Technology (DST), Department of Biotechnology (DBT), Department of AYUSH, Quality Council of India (QCI), National Research Development Corporation (NRDC) and Indian Council for Medical Research (ICMR), held at New Delhi (29-30 August 2011).
  21. International Conference and CME cum Workshop on Pharmacovigilance Systems and Rational Use of Drugs: An Integrated Approach (“Vision for Sustainable Pharmacovigilance in India”) organized by Deptt. of Pharmacology, Lady Hardinge Medical College, New Delhi (26-28 November, 2010).
  22. 2nd Biennial International Conference on “New Developments in Drug Discovery from Natural Products and Traditional Medicines” organized by the Department of Natural Products at National Institute of Pharmaceutical Education and Research (NIPER), Punjab (20-24 November, 2010: Oral Presentation).
  23. National Seminar on “Recent Trends in Pharmacy Education and Practice” conducted by Pharmacy Council of India (PCI) at Vigyan Bhavan, New Delhi (July 9-10, 2010).
  24. Participated in “Summer School Cutting Edge Technologies in the Life Sciences” in Hamdard University, New Delhi (15 June, 2010 to 30 June, 2010).
  25. International Conference on “Recent Advances in Cardiovascular Sciences” at Delhi Pharmaceutical Sciences and Research University, New Delhi (3rd & 4th February, 2010).
  26. 54th Annual National Conference of Association of Physiologists and Pharmacologists of India (APPICON-2009) at Saifai, Etawah (U.P.) (December 3-6, 2009: Oral Presentation).
  27. National Conference on ‘Medical Devices’ Moving up the value chain sponsored by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, at Federation House, FICCI, New Delhi (8th October, 2009).
  28. International Seminar on ‘Centenary Celebration of All India Ayurvedic Congress’, SIRI Fort Auditorium, New Delhi, India, sponsored by Department of Ayush, Ministry of Health and Family Welfare, Government of India (attended only on 7th October, 2009).
  29. Workshop for the Inspectors of the Pharmacy Council of India (PCI) at Indian National Science Academy (INSA), New Delhi (5th October, 2009) (Ref. No. 14-133/2009-PCI; 14-18/2005-PCI/17424-578 dated 11September, 2009).
  30. AICTE sponsored National Seminar on ‘Emerging Trends in Pharmaceutical Sciences’, Hamdard University, New Delhi (21-22 March, 2009).
  31. Seminar on ‘Intellectual Property Rights Protection & Management’ organized by the National Research Development Corporation in collaboration with Central Council for Research in Unani Medicine (CCRUM), Hamdard University, New Delhi (11-12 February, 2009).
  32. International Conference on Translational Pharmacology & 41st Annual Conference of Indian Pharmacological Society (IPS), AIIMS, New Delhi (18-20 December, 2008).
  33. 60th Indian Pharmaceutical Congress (IPC), New Delhi (12-14 December, 2008).
  34.  Workshop on “Real Time PCR”, Hamdard University, New Delhi (26-27 December,   2007).
  35. 59th Indian Pharmaceutical Congress (IPC), Varanasi, U.P. (20-23 December, 2007).
  36. One day Seminar on “Syntheses and Characterization of Nanomaterials” by Society of Analytical Chemists, Jamia Hamdard, New Delhi (17th November, 2007).
  37. International Conference on Research Advances in Traditional Medicine: Challenges and Opportunities, Jamia Hamdard, New Delhi, India (30-31st October, 2007).
  38. One day Interactive session on “Putting Herbals Centre Stage: Pharmacopeial Initiative organized by Indian Pharmaceutical Association, Delhi Branch and Indian Pharmacopeial Commission, New Delhi (1st September, 2007). 
  39. National Symposium on “Awareness, Preparedness and Mitigation of Exposure to Domestic and Industrial Chemicals (EPMEDIC-2007)”, New Delhi (30-31st August, 2007).
  40. Workshop on “Rheumatoid Arthritis” organized by Central Council for Research in Unani Medicine, Ministry of Health, New Delhi (27-28th August, 2007).
  41. Workshop on “Herbal Insect Repellants: New Developments”, New Delhi (24th June, 2007).
  42. Annual Conference of the Indian Society of Hypertension & International Symposium on Atherosclerosis in Hypertension, Diabetes and Coronary Artery Disease (BPCON 2007), CDRI, Lucknow, India (15-16 March, 2007).
  43. 39th Annual Conference of the Indian Pharmacological Society (IPS), Jaipur, Rajasthan, India (21-23 December, 2006).
  44. International Symposium on “Herbal Drug Research and Therapy”, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India (09-10th December, 2006).
  45. National Seminar on Medicinal Plants: Conservation, cultivation and utilization, Gurukul Kangri Vishwavidyalaya, Haridwar, Uttranchal, India (9-11 March, 2006).
  46. 3rd North Zone Conference of Indian Pharmacological Society, New Delhi, India (23 April, 2005).
  47. Seminar on” Intellectual Property Rights Awareness in Pharmaceuticals” Hamdard University, New Delhi, India (26 Feb, 2005).
  48. International Conference on Unani Medicine, New Delhi, India (8-11 Feb, 2005).
  49. International Workshop on Adverse Drug Reaction Monitoring & 4th Annual Conference of Pharmacovigilance Society of India, Bareilly, UP, India (Jan 22-23, 2005).
  50. Joint International Conference of International Society for Heart Research (Indian Section) & International Academy of Cardiovascular Sciences (India Section), Ahmedabad, India (Dec. 31-Jan2, 2005).
  51. Indo-UK Seminar on Biomarkers of Ecotoxicity, Cancer, Monitoring and Prevention, Jamia Hamdard, New Delhi (29 Aug, 2004).
  52. International Symposium on Recent Advances in Pharmacology, New Delhi India (7-8 Jan, 2004).
  53. 36th Annual Conference of Indian Pharmacological Society, Delhi, New India (5-7, Dec., 2003).
  54. Update on Newer Drug Development for HIV/ AIDS and in Ocular  Pharmacology, AIIMS, New Delhi (7th Sept, 2003).
  55. Symposium on Poison Information Network in India (NPIC-2001), AIIMS, New Delhi (17-19 Dec., 2001).
  56. Symposium on Challenges in Clinical Pharmacology, Vallabhbhai Patel Chest Institute, Univ of Delhi, Delhi, (10th Nov. 2001).
  57. Annual conference of International Society for Heart Research (Indian Section), AIIMS, New Delhi (22-29 Jan., 2001).
  58. 5th Annual Convention of Association of Pharmaceutical Teachers of India (ATPI), Udaipur, Rajasthan (4-5 Sep., 2000).
  59. International Congress on Frontiers in Pharmacology and Therapeutics in 21st Century, New Delhi, India (1-4 Dec. 1999).
  60. International Symposium on New Drug Development, (Feb. 6-8, 1998), New Delhi, India.
  61. International Seminar on "Recent trends in Pharmaceutical Sciences", Ootacamund, Tamil Nadu, India (18-20 Feb. 1995).
  62. 27th Annual Conference of Indian Pharmacological Society, Bombay, India (21-24 Dec. 1994).
  63. 26th Annual Conference of Indian Pharmacological Society, Hisar, Haryana, India (25-27 Nov. 1993).
  64. Update on Clinical Ocular Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India (23rd Nov. 1993).
  65. 21st Annual Conference of Indian Pharmacological Society, Hyderabad, India (29-31 Dec., 1988).
  66. 39th Indian Pharmaceutical Congress Madras, India (1-3 Jan., 1988).
Number Of Presentations In International Conferences Abroad :

12

Please Specify Invited/Oral/Poster :
  1. Virtual Presentation in a Science at a Glance (SaaG Poster Session) in an international Conference, 88th European Atherosclerosis Society (EAS), 2020 (Geneva Switzerland), from Oct. 04-07-2020 (Virtual Congress).
  2. Oral presentation in an International Conference on Disease Biomarkers and Precision Medicne organized by United Scientific Group at Houston (USG), TX 77032 USA from October 22-24, 2018 and presented the paper entitled ‘ Diagnostic Evaluation of Various Biomarkers in Non Alcoholic Fatty Liver Disease’.
  3. Poster presentation in XVIII International Symposium on Atherosclerosis (ISA 2018) organised by International Atherosclerosis Society at Toronto, Ontario, Canada, June 10-12, 2018 and the poster entitled’ Effect of embelin in Monosodium Glutamate Induced Obesity in Neonatal Wistar Rats’.
  4. Oral presentation in 2nd International Conference on Obesity and Chronic Diseases(ICOCD-2017) at San Francisco, CA, USA, July 06-08, 2017 and presentated the paper entitled ‘Antiobesity potential of Embelin in high fat diet-induced obesity in Wistar rats’.
  5. 2nd World Congress on Targeting Microbiota, 2014, ‘ Embelin suppresses gut microbiota – induced proatherosclerotic  metabolite , Trimethylamine –N-Oxide (TMAO) level in choline fed Wistar rats’. (Poster Presentation)  Paris, France, Oct. 16-17, 2014.
  6. 81 European Atherosclerosis Society (EAS) Congress Lyon, France (2-5 June, 2013) Attended Gordon Research Conference on Lipoprotein Metabolism at Waterville Valley, New Hampshire, USA (17-22 June, 2012).
  7. 3rd International Symposium on Pharmacology of Natural products (FAPRONARURA 2012), Havana, Cuba (6-10 June, 2012) and presented the paper (Plenary Lecture) entitled ‘Association of cardiomyocyte apoptosis with metabolic syndrome in type 2 diabetic rats with obesity: potential of Gymnemic Acid-Phospholipid Complex (GPC)’.
  8. 79th European Atherosclerosis Society (EAS) Congress, Gothenburg, Sweden (26-29 June,      2011) and presented the paper entitled ‘Molecular insights into cardiomyocyte apoptosis:  Treatment with pioglitazone in low-dose streptozotocin and high fat diet fed obesity in murine model (Poster No. 3.39)’ Atherosclerosis [Supplement], 2011, 12 (1): 106.
  9. Obesity 2010, 28th Annual Scientific Meeting, San Diego, USA (8-12 October, 2010) and presented the paper entitled ‘Preventing Cellular Obesity Changes and Target Organ Damage: The Heart by Ethanolic Gymnema sylvestre in Murine Model of Obesity (745-P)’. Obesity supplement, 2010, Volume 18.
  10. XV World Congress of Pharmacology (IUPHAR), Beijing, CHINA (2-7 July 2006) and presented the paper entitled ‘Blood Pressure Lowering & Antioxidant Potential of Aqueous Extract of Embelia ribes in Diabetic Rats (P280008)’ Acta Pharmacologica Sinica (Supplement), 2006, 1:297.
  11. XIV World Congress of Pharmacology (IUPHAR), San Francisco, USA (7-12 July 2002)

     and presented paper entitled ‘Prevention of diabetic dyslipidemia by Embelia ribes and

     Ocimum sanctum in streptozotocin-induced diabetic rats.

12.   XIIIth International Congress of Pharmacology (IUPHAR), Munchen, Germany (26-31 July, 1998) and presented paper entitled ‘Prevention and reduction of hypercholesterolemia by Zingiber officinale in rabbits on atherogenic diet (P 51.16)’

NATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

1. National Achiever of the Year, 2023

2. Distinguised Researcher Award

3. Best Academician of the Year 2022 

4. Certificate of Appreciation and incentive

5. Shiksha Rattan Puraskar 

6. Certificate of Recognition’ and an amount of Rs.5000/- awarded

7.  Scientist of the Year Award 

8.  award and medal for securing Ist position in M. Pharma (Pharmacology), 

 

ICMR-Research Associate Fellowship: One

Title: To investigate the potential of saroglitazar against monosodium glutamate –induced obesity and associated comorbidities in Wistar rats.

Candidate: Sayima Nabi, Fellowship awarded in March, 2022.

JAMIA HAMDARD SILVER JUBILEE FELLOWSHIP: One

  1. Title: Evaluation of antiobesity potential of Saroglitazar in monosodium glutamate 

obese neonatalWistar rats.

Candidate: Sayima Nabi, Fellowship awarded in Oct, 2018

HAMDARD NATIONAL FOUNDATION FELLOWSHIP (HNF): Two

  1. Title: Assessment of the potential of anti- PCSK9 monoclonal antibody (mAb1)

and atorvastatin alone and in combination in murine model of atherogenesis and

  • .

Candidate: Priyanka Arya Fellowship awarded in April 2019- March 2020 & Sep,

  1.  
  1. Title: Evaluation of antiobesity potential of Saroglitazar in monosodium glutamate 

obese neonatalWistar rats.

Candidate: Sayima Nabi, Fellowship awarded in Sep, 2021.

 

 

UGC NET ASSISTANT PROFESSORSHIP: Two

  1. Title: Effect of embelin in metabolic endotoxemia mediated- inflammation & associated obesity induced by high fat diet in C57BL/6 mice.

Candidate: Priyanka Bansal, Qualified in July, 2018

  1. Title Assessment of the potential of anti- PCSK9 monoclonal antibody (mAb1)and atorvastatin alone and in combination in murine model of atherogenesis 

Candidate: Priyanka Arya, Qualified in June, 2019

Granting Agency :

1. Centre for Education Growth and Research (CEGR) 

2. Centre for Women Development,Venus International Foundation,

3. Centre for Education Growth and Research (CEGR) 

4. Jamia Hamdard 

5. Certificate of Excellance by India International Friendship Society, New Delhi, India 

6. Jania Hamdard  

7. National Environmental Science Academy, New Delhi

8. Indian Pharmaceutical Association (IPA)

 

Year Of Award :

1. 2023

2. 2023

3. 2022

4. 2016

5.  2012

6. 2011

7. 2007

8. 1988

INTERNATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

1. Travel GRANT AWARD

2. ICMR Travel Grant Award 

3. Nature Travel Grant 

4. INSA Delegate travel grant 

5. US Travel Grant Award 

6. (Category 1) of travel grant 

Granting Agency :

1. Jamia Hamdard 

2. ICMR 

3. Nature Publishing Group (NPG, USA office) 

4. Indian National Science Academy (INSA)

5. IUPHAR (International Union of Pharmacology)

6. Indian National Science Academy (INSA)

Year Of Award :

1. 2018

2.2012

3. 2012

4. 2006

5. 2002

6. 1998

STAFF DEVELOPMENT/REFRESHER/SHORT TERM TRAINING PROGRAMME/WEBINARS ORGANIZED

Title :

 

  1. As Chairperson, Women Development Cell, Organised Health camp in Jamia Hamdard       
             Camp in collaboration with Titan Eye Plus on 18th Feb 2025
  2. Organised the International Women’s day celebration as Chairperson, Women Development Cell on 8th March 2024, in Jamia Hamdard, New Delhi.
  3. Organised Free Eye Camp in collaboration with Titan Eye Plus, as Chairperson, Women Development Cell on 5th March 2024, in Jamia Hamdard, New Delhi.
  4. ‘UGC SAP sponsored National Conference on Chronic Inflammatory Disorders’ organized by Hamdard University (Jamia Hamdard), New Delhi, (13-15 Feb., 2014)

Duration :

Sponsoring Agency :

MEMBER(S) OF NATIONALCOMMITTEES

  1. Member of International Science Council, USA since 2020
  2. Nominee, CPCSEA, Ministry of Environment, Govt. of India w.e.f. Jan., 2014
  3. Life Member, Asian Polymer Association (No.L324) since Jan, 2012.
  4. Life Member, The Indian Society for Atherosclerosis Research (LM-331) (w.e.f. Sept, 2011).
  5. European Atherosclerosis Society (No.3233), 2009,2010, 2012, 2019
  6. Member, Obesity Society, USA (2010)
  7. Member, New York Academy of Sciences, USA, 2003.
  8. Member, American Diabetes Association, USA, 2000, 2001.
  9. Life Member, National Environmental Science Academy.
  10. Life Member, Indian Society of Analytical Scientist.
  11. Life Member, Indian Society of Hypertension.
  12. Life Member, Indian Society of Pharmacovigilance.
  13. Life Member, Indian Society of Heart Research (ISHR).
  14. Life Member, Indian Society for Technical Education (ISTE).
  15. Life Member, Indian Pharmacological Society (IPS).
  16. Life Member, Indian Toxicological Society (ITS).
  17. Life Member, Association of Pharmaceutical Teachers of India (APTI).

MEMBER(S) OF INTERNATIONAL COMMITTEES

  1. Member of International Science Council, USA since 2020
  2. Nominee, CPCSEA, Ministry of Environment, Govt. of India w.e.f. Jan., 2014
  3. Life Member, Asian Polymer Association (No.L324) since Jan, 2012.
  4. Life Member, The Indian Society for Atherosclerosis Research (LM-331) (w.e.f. Sept, 2011).
  5. European Atherosclerosis Society (No.3233), 2009,2010, 2012, 2019
  6. Member, Obesity Society, USA (2010)
  7. Member, New York Academy of Sciences, USA, 2003.
  8. Member, American Diabetes Association, USA, 2000, 2001.
  9. Life Member, National Environmental Science Academy.
  10. Life Member, Indian Society of Analytical Scientist.
  11. Life Member, Indian Society of Hypertension.
  12. Life Member, Indian Society of Pharmacovigilance.
  13. Life Member, Indian Society of Heart Research (ISHR).
  14. Life Member, Indian Society for Technical Education (ISTE).
  15. Life Member, Indian Pharmacological Society (IPS).
  16. Life Member, Indian Toxicological Society (ITS).
  17. Life Member, Association of Pharmaceutical Teachers of India (APTI).

ADMINISTARTIVE RESPONSIBILITIES/ PARTICIPATION IN COMMITTEES OF JAMIA HAMDARD

 

1.Appointed as Officiating Dean of School of Pharmaceutical Education and Research  by Vice Chancellor from, Jamia Hamdard 

2. Appointed as Officiating Head of Department of Pharmacology, School of Pharmaceutical  Education and Research  by  Vice Chancellor from, Jamia Hamdard 

3. Appointed as Chancellor Nominee for Selection Committee for CAS promotion from Assistant Professor (Stage-3) to Associate Professor (Stage-4) for the subject of Statistics (Re-assessment case) in the School of Pharmaceutical Education and Research  (SPER),

4. Appointed as Chairman of Scientific committee in 27th Convention of Indian Society of Pharmacognosy and International Conference “Role of Traditional Medicine and Phytopharmaceuticals in Health Care for Viksit Bharat”, Jamia Hamdard, 4th and 5th October, 2024.Jamia Hamdard. Interview held on 25-11-2024.

5. Appointed as Chairperson, Women Development Cell, by competent authority, Jamia Hamdard for a period of two years on 05-01-2024.

6. Appointed as VC Nominee to be part of the Panel for  interviews  for the shortlisted PhD Candidates of (Cycle I), Session 2023-24  for the School of Interdisciplinary Sciences and Technology (SIST) by Competent authority of Jamia Hamdard  on 07-12-2023

7. VC Nominee for the selection committee as an Expert Member in the panel of the Examiners for conducting the interview for the selection of SRF in the ICMR project of Prof. Suhel Parvez, SCLS, Jamia Hamdard on 21-06-2023.

8. Member, allocation of Supervisors to M Pharm (Pharmacology and Pharmacy Practice) Candidates, in the meeting held on 22-07-2022.

9. ‘Team leader’, Flying Squad Team for annual/End examination -2022 in various  Schools  (SPER; Department of Management, Department of Paramedical Sciences, Department of Media and Mass Communication, Department of Computer Science and Engineering) as approved by Competent Authority on 27th July, 2022.

10. Member of Board of study of the Department 

 

ANY OTHER

 

  1. Nominated member of American Biographical Institute's Professional Women’s Advisory Board since 2004.
  2. Set up Pharmacy Department in the Capacity of Director (Founder), Pharmacy, IIMT, College of Medical Sciences, Meerut Affiliated to U.P. Technical University, Lucknow, U.P. in the pay scale of Rs. 20,400-500-Rs. 22,400 after availing one year extra-ordinary leave from Hamdard University; from 11-07-2005 to 10-07-2006.
  3. Inclusion in the Panel of Inspectors of Pharmacy Council of India (PCI) [Ref. No. 1-2//2006Pt.I-PCI-6692-822, dated 25th June, 2007].
  4. Visited Central Research Institute (Ayurveda), Gwalior, Madhya Pradesh in connection with setting up Pharmacy and Pharmacological Laboratories of the Institute (30 and 31st October, 2006).
  5. Nominated as Member by DG, ICMR, Project Review Committee of Indian Council of Medical research (ICMR), New Delhi in the subject of Pharmacology w.e.f May, 2012. (Ref. No 58/48/2011-BMS, dated 18/05/2012)
  6. ‘Internal Examiner’ for evaluation of thesis and viva-voce for M.Pharma IV Semester examination (MPG-401) in the Department of Pharmacology, SPER, Jamia Hamdard.
  7. Subject Expert for the Selection Committee meeting for the Pharmaceutical Sciences by PDM University ,Haryana held on 8th August 2017
  8. External Examiner’ for setting of the question paper of the M.Pharma Pharmacology in the subject, Advanced Pharmacology (MPL-102T) in Jamia Hamdard, New  Delhi,  in Oct. 2018.
  9. External Examiner’ for setting of the question paper of the M.Pharma (Pharmacology/Pharmaceutics) in the subject, Research Methodology and Statistics (MPL-301T & MPH-301T) in BB Ambedkar University, Lucknow in Nov. 2018. 
  10. Member, Institiutional ANIMAL Ethics Committee Meeting (I
  11. Attended as an Expert member  (CPCSEA Nominee) in Institutional Animal Ethics Committee (IAEC) meeting held in INMAS, DRDO on 10th June, 2019.
  12. As Organizing Secretary, conducted UGC-SAP DRS-II Sponsored Seminar on Recent Advances in Pharmacotherapeutics on 28th March, 2019, SPER, Jamia Hamdard.
  13. Appointed as an Expert to evaluate the proposals received for National Research Development Corporation (NRDC) National Meritorious Invention Awards Programme in Sept, 2019.
  14. Attended as an Expert in Union Public Selection Commission (UPSC) Interview Board for the interview of Scientific Officer (Pharmacology) held in UPSC, New Delhi on 12th June, 2019.
  15. Appointed as an Examiner for setting of question paper and evaluation of answer books of Ph.D. course work in Cardiovascular Pharmacology (PhD PCOL 103) by the Jamia Hamdard in August 2019.
  16. Appointed as Expert on 16th Sept. 2019 for evaluating the proposal received for National Research Development Corporation (NRDC) on behalf of DSIR, New Delhi.
  17. External Examiner to evaluate the Ph.D. thesis of Ph.D. candidate from Panjab University, Chandigarh, India in Sept. 2019.
  18. Empanelled with Tata Consultancy Services (TCS iON) as a Subject Matter Expert for Pharmacology in January 2021.
  19. Attended as an Expert in Union Public Selection Commission (UPSC) Interview for the insitu promotion of Scientists of Central Drug Laboratory of Kolkata, W.B. held in UPSC, New Delhi on 29 Dec 2020 IAEC), INMAS, 11th April,2018
  20. NAAC Assessor : Nominated by NAAC ( National Assessment and Accreditation Council) of UGC, Govt. of India 
  21. As an External Examiner to evaluate the Ph.D. thesis of Ph.D. candidate from Deptt. of Pharmaceutical Sciences, Amity Institute of Pharmacy, Amity University, Uttar Pradesh, India in February, 2022.
  22. Appointed as Internal Examiner for the B.Pharm Semester VII (Regular & SFS) Examination of the Subject of Practice School (BP 706PS) by  Jamia Hamdard in January, 2022.
  23. Appointed as an Examiner for setting of question paper  of Ph.D. Course Work of the Subject Basic Pharmacology (PhD PCOL 102) by the Jamia Hamdard in August, 2022.
  24. Member, allocation of Supervisors to M Pharm (Pharmacology and Pharmacy Practice) Candidates, in the meeting held on 22-07-2022.

Designed & Devloped by HAH-CIT

© 2025 Jamia Hamdard

V I S I T O R S : - 2 7 9 4 8 4 3